Feng Chi Biotech Corp.(TW:6744)
NT$12.900.00 (0.00%)
TW:6744
Feng Chi Biotech Corp. Revenue
NT$12.90
At close:0.00 (0.00%)
Feng Chi Biotech Corp. (6744) Revenue
Feng Chi Biotech Corp. Revenue
Feng Chi Biotech Corp. had a revenue of 75.67M in the quarter ending Jun 30, 2026, with -6.95%. This bring the company's revenue in the last twelve months to 156.99M, Decreased 11.49%. In the fiscal year ending Dec 31, 2025, Feng Chi Biotech Corp. had annual revenue of 177.36M with 3.66% growth.
- Revenue (ttm)
- 156.99M
- Revenue Growth
- -12.75%
- P/S Ratio
- 1.07
- Revenue/Employee
- TWD 5,542,500
- Employees
- 32
- Market Cap
- TWD 189.50M
Revenue Chart
Feng Chi Biotech Corp. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 177.36M | 6.26M | 3.66% |
| Dec 31, 2024 | 171.10M | -9.48M | -5.25% |
| Dec 31, 2023 | 180.58M | -12.88M | -6.66% |
| Dec 31, 2022 | 193.46M | 10.89M | 5.96% |
| Dec 31, 2021 | 182.57M | 3.66M | 2.05% |
| Dec 31, 2020 | 178.91M | 4.58M | 2.63% |
| Dec 31, 2019 | 174.33M | 26.25M | 17.72% |
| Dec 31, 2018 | 148.08M | 23.40M | 18.77% |
| Dec 31, 2017 | 124.68M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.